表紙
市場調査レポート

ダニ媒介性脳炎:世界の治験レビュー

Tick Borne Encephalitis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 310341
出版日 ページ情報 英文 62 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
ダニ媒介性脳炎:世界の治験レビュー Tick Borne Encephalitis Global Clinical Trials Review, H2, 2014
出版日: 2014年07月31日 ページ情報: 英文 62 Pages
概要

当レポートでは、ダニ媒介性脳炎に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • ダニ媒介性脳炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対するダニ媒介性脳炎の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:中枢神経系の治験件数に対するダニ媒介性脳炎の治験件数比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的な企業における治験の概要
    • Baxter International Inc.
    • Novartis AG
    • Microgen Scientific Industrial Company for Immunobiological Medicines
  • 代表的な研究機関・病院の治験の概要
    • Medical University of Vienna
    • Institut fur Speziale Prophylaxe und Tropenmedizin
    • The National Institute of Allergy and Infectious Diseases
    • University of Surrey
    • University of Zurich
    • Malar Hospital
    • Sormland County Council
    • Elisabethinen Hospital

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Tick Borne Encephalitis Global Clinical Trials Review, H2, 2014" provides data on the Tick Borne Encephalitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tick Borne Encephalitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tick Borne Encephalitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Tick Borne Encephalitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Tick Borne Encephalitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Tick Borne Encephalitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Microgen Scientific Industrial Company for Immunobiological Medicines
      • Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines
    • Clinical Trial Overview of Top Institutes / Government
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Institut fur Speziale Prophylaxe und Tropenmedizin
      • Clinical Trial Overview of Institut fur Speziale Prophylaxe und Tropenmedizin
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Surrey
      • Clinical Trial Overview of University of Surrey
      • University of Zurich
      • Clinical Trial Overview of University of Zurich
      • Malar Hospital
      • Clinical Trial Overview of Malar Hospital
      • Sormland County Council
      • Clinical Trial Overview of Sormland County Council
      • Elisabethinen Hospital
      • Clinical Trial Overview of Elisabethinen Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Tick Borne Encephalitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut fur Speziale Prophylaxe und Tropenmedizin, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Surrey, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Malar Hospital, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sormland County Council, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Elisabethinen Hospital, 2014*

List of Figures

  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Tick Borne Encephalitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • GlobalData Methodology
Back to Top